In the context of PCa, IL-8-mediated CXCR2 signalling on cancer cells, ECs, and immune cells enhances these processes, further supporting tumour growth, metastasis, and treatment resistance. This evidence concerns the gene CXCL8 and posterior cortical atrophy.